: The distribution of lysine residues (yellow) for CDK2 (PDB id 1VYZ), CDK5 (PDB id 1UNG) and CDK9 (PDB id 4BCG) are shown below. Inhibitor is shown in magenta.
 N-(3-cyclobutyl-1H-pyrazol-5-yl)-2-(4-methoxyphenyl) 
methyl 2-(4-((5-bromopentyl)oxy)phenyl)acetate:
In a round-bottom flask, compound 8 (0.30g, 1.8 mmol) and K 2 CO 3 (0.30g, 2.16 mmol) were dissolved in acetone (10 mL). Reaction mixture was stirred for 10 minutes followed by addition of 1,5-dibromopentane (0.82g, 3.6 mmol) and the resulting mixture was refluxed for 72 h. Acetone was evaporated ad the crude mixture was dissolved in ethyl acetate and washed with saturated ammonium chloride and brine, the combined organic layer was dried over MgSO 4 . After filtration and evaporation, the residue was purified by flash column chromatography to give 9 as a colorless liquid (0.44g, 77% yield). 78, 158.26, 130.39, 125.28, 114.63, 67.56, 40.09, 33.54, 32.46, 28.40, 24 .82.
2-(4-((5-bromopentyl)oxy)phenyl)acetic acid:
To a solution of 9 (0.44g, 1.4 mmol) in 10 mL of ethanol was added lithium hydroxide (0.10g, 4.19 mmol) in water (3 mL) and reaction mixture was stirred at room temperature for 16h. Solvent was evaporated and the crude mixture 35, 158.10, 130.25, 126.01, 114.58, 67.56, 51.97, 40.29, 33.56, 32.47, 28.42, 24.83 . 5-(2-(4-((5-bromopentyl) 14, 161.08, 158.53, 150.89, 141.42, 130.51, 125.63, 115.06, 95.43, 86.26, 67.65, 43.64, 34.31, 33.53, 32.44, 28.39, 27.92, 24.83, 18.69 . 
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